Head-to-head · WeighScore
Valhalla Vitality vs WeightCare
By GLP-1 ScorecardUpdated
Score comparison
Valhalla Vitality has the higher recorded score — 63.6/100 to 52.2/100.
Valhalla Vitality grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Valhalla Vitality is a telehealth wellness platform offering compounded semaglutide and tirzepatide for weight loss, alongside peptide and hormone therapies.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Valhalla Vitality | WeightCare |
|---|---|---|
| WeighScore | 63.6/100 | 52.2/100 |
| Grade | C | C |
| Site position | #284 | #522 |
| Semaglutide | $449/mo (compounded) | $399/mo |
| Tirzepatide | $449/mo (compounded) | $499/mo (15 mg dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #284 · C
Strengths
- LegitScript-certified pharmacy partner
- Offers both compounded semaglutide and tirzepatide
- No membership fees and free consultations
- Add-on peptide and hormone therapies plus at-home labs
What to consider
- Compounded GLP-1 only, no FDA-approved branded options
- Pricing not transparently listed on the main site
- Compounded drugs are not FDA-approved for safety or efficacy
- States served not clearly disclosed
Site position #522 · C
FDAWarning letter issued to Weightless Medical LLC dba WeightCare in February 2026. See the FDA warning-letter database.
Strengths
- PCAB-accredited pharmacy partners — strongest pharmacy quality signal
- Quality testing: potency and sterility per USP 797 standards
- 85,000+ members since 2022 — established patient base
- Multiple program tiers for semaglutide
- Health coaching, dietitians, fitness trainers included
What to consider
- No LegitScript certification on the site itself
- State availability not explicitly listed
- Compounded only — no brand-name options
- Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose
- FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.